Testosterone does not affect lower urinary tract symptoms while improving markers of prostatitis in men with benign prostatic hyperplasia: a randomized clinical trial

PURPOSE: Benign Prostatic Hyperplasia (BPH) is a result of prostate inflammation, frequently occurring in metabolic syndrome (MetS). Low testosterone is common in MetS. A randomized clinical trial was designed to evaluate if 24 weeks of testosterone therapy (TTh) in BPH men with MetS and low testost...

Descripción completa

Detalles Bibliográficos
Autores principales: Rastrelli, G., Cipriani, S., Lotti, F., Cellai, I., Comeglio, P., Filippi, S., Boddi, V., Della Camera, P. A., Santi, R., Boni, L., Nesi, G., Serni, S., Gacci, M., Maggi, M., Vignozzi, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184417/
https://www.ncbi.nlm.nih.gov/pubmed/35298833
http://dx.doi.org/10.1007/s40618-022-01776-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184417/
https://www.ncbi.nlm.nih.gov/pubmed/35298833
http://dx.doi.org/10.1007/s40618-022-01776-9

Ejemplares similares